UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Viral and Synthetic RNA Vector Technologies and Applications

Molecular therapy, 2016-09, Vol.24 (9), p.1513-1527

2016

Link zum Volltext

Verfügbarkeit prüfen

Bromo- and Extraterminal Domain Chromatin Regulators Serve as Cofactors for Murine Leukemia Virus Integration

Journal of Virology, 2013-12, Vol.87 (23), p.12721-12736

2013

Link zum Volltext

Verfügbarkeit prüfen

Recombinase-Mediated Cassette Exchange (RMCE): Traditional Concepts and Current Challenges

Journal of molecular biology, 2011-03, Vol.407 (2), p.193-221

2011

Link zum Volltext

Verfügbarkeit prüfen

Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming

Molecular therapy, 2011-04, Vol.19 (4), p.782-789

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance

Nature communications, 2020-02, Vol.11 (1), p.1114-1114, Article 1114

2020

Link zum Volltext

Verfügbarkeit prüfen

Gammaretroviral vectors: biology, technology and application

Viruses, 2011-06, Vol.3 (6), p.677-713

2011

Link zum Volltext

Verfügbarkeit prüfen

Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis

PLoS genetics, 2014-08, Vol.10 (8), p.e1004558

2014

Link zum Volltext

Verfügbarkeit prüfen

Protein transduction from retroviral Gag precursors

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (17), p.7805-7810

2010

Link zum Volltext

Verfügbarkeit prüfen

MCK2-mediated MCMV infection of macrophages and virus dissemination to the salivary gland depends on MHC class I molecules

Cell reports (Cambridge), 2023-06, Vol.42 (6), p.112597-112597, Article 112597

2023

Link zum Volltext

Verfügbarkeit prüfen

Generation of an NFκB-Driven Alpharetroviral "All-in-One" Vector Construct as a Potent Tool for CAR NK Cell Therapy

Frontiers in immunology, 2021-11, Vol.12, p.751138-751138

2021

Link zum Volltext

Verfügbarkeit prüfen

Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs

Stem cell research & therapy, 2023-09, Vol.14 (1), p.1-270, Article 270

2023

Link zum Volltext

Verfügbarkeit prüfen

Self-Inactivating Alpharetroviral Vectors with a Split-Packaging Design

Journal of Virology, 2010-07, Vol.84 (13), p.6626-6635

2010

Link zum Volltext

Verfügbarkeit prüfen

Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout

Molecular therapy. Nucleic acids, 2018-12, Vol.13, p.256-274

2018

Link zum Volltext

Verfügbarkeit prüfen

Retrovirus Vectors: Toward the Plentivirus?

Molecular therapy, 2006-06, Vol.13 (6), p.1050-1063

2006

Link zum Volltext

Verfügbarkeit prüfen

Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells

Molecular therapy. Nucleic acids, 2022-03, Vol.27, p.810-823

2022

Link zum Volltext

Verfügbarkeit prüfen

CRISPR/Cas9 Immunoengineering of Hoxb8-Immortalized Progenitor Cells for Revealing CCR7-Mediated Dendritic Cell Signaling and Migration Mechanisms in vivo

Frontiers in immunology, 2018-08, Vol.9, p.1949-1949

2018

Link zum Volltext

Verfügbarkeit prüfen

Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells

Retrovirology, 2017-05, Vol.14 (1), p.34-34, Article 34

2017

Link zum Volltext

Verfügbarkeit prüfen

Viral and non-viral approaches for transient delivery of mRNA and proteins

Current gene therapy, 2011-10, Vol.11 (5), p.382

2011

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells

Retrovirology, 2017-10, Vol.14 (1), p.48-48, Article 48

2017

Link zum Volltext

Verfügbarkeit prüfen

Cellular Restriction of Retrovirus Particle-Mediated mRNA Transfer

Journal of Virology, 2008-03, Vol.82 (6), p.3069-3077

2008

Link zum Volltext

Verfügbarkeit prüfen

Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase

Molecular therapy. Methods & clinical development, 2016-01, Vol.3 (C), p.16038-16038, Article 16038

2016

Link zum Volltext

Verfügbarkeit prüfen

Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes

Journal of autoimmunity, 2019-09, Vol.103, p.102289-102289, Article 102289

2019

Link zum Volltext

Verfügbarkeit prüfen

Retroviral gene therapy in Germany with a view on previous experience and future perspectives

Gene therapy, 2021-09, Vol.28 (9), p.494-512

2021

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity

Immunity (Cambridge, Mass.), 2016-02, Vol.44 (2), p.233-245

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(37)
Animals
(24)
Humans
(22)
Mice
(19)
Medicine, Research & Experimental
(14)
Research & Experimental Medicine
(14)
Genetic Vectors
(12)
Cell Line
(11)
Gene Therapy
(10)
Genetics & Heredity
(9)
Genetic Vectors - Genetics
(8)
Biotechnology & Applied Microbiology
(7)
Dna
(7)
Genomes
(7)
Retroviridae - Genetics
(7)
Transduction, Genetic
(7)
Deoxyribonucleic Acid
(6)
Expression Vectors
(6)
Gene Transfer Techniques
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Viral and Synthetic RNA Vector Technologies and Applications

Bromo- and Extraterminal Domain Chromatin Regulators Serve as Cofactors for Murine Leukemia Virus Integration

Recombinase-Mediated Cassette Exchange (RMCE): Traditional Concepts and Current Challenges

Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming

Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance

Design and Characterization of an “All-in-One” Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines

Gammaretroviral vectors: biology, technology and application

Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis

Protein transduction from retroviral Gag precursors

MCK2-mediated MCMV infection of macrophages and virus dissemination to the salivary gland depends on MHC class I molecules

Generation of an NFκB-Driven Alpharetroviral "All-in-One" Vector Construct as a Potent Tool for CAR NK Cell Therapy

Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs

Self-Inactivating Alpharetroviral Vectors with a Split-Packaging Design

Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout

Retrovirus Vectors: Toward the Plentivirus?

Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells

CRISPR/Cas9 Immunoengineering of Hoxb8-Immortalized Progenitor Cells for Revealing CCR7-Mediated Dendritic Cell Signaling and Migration Mechanisms in vivo

Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells

Viral and non-viral approaches for transient delivery of mRNA and proteins

Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells

Cellular Restriction of Retrovirus Particle-Mediated mRNA Transfer

Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase

Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes

Retroviral gene therapy in Germany with a view on previous experience and future perspectives

In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity

Suchergebnisse filtern